Red cell distribution width in heart failure: Prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state

American Heart Journal

Volumn 158, Issue 4, 2009, Pages 659-666

  Förhécz, Zsolt ^a   Gombos, Tímea ^a   Borgulya, Gábor ^b   Pozsonyi, Zoltán ^a   Prohászka, Zoltán ^a,b   Jánoskuti, Lívia ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; FERRITIN; INTERLEUKIN 6; IRON; PREALBUMIN; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE MARKER; ERYTHROCYTE VOLUME; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEART FAILURE; HOSPITAL READMISSION; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE REGRESSION; NUTRITIONAL STATUS; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; VALIDATION STUDY;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; HUNGARY; INFLAMMATION; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PATIENT READMISSION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TIME FACTORS;

EID: 70349213219     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.07.024     Document Type: Article

References (29)

1. Morris M., and Davey F.R. Basic examination of blood. In: Henry J.B. (Ed). Clinical diagnosis and management by laboratory methods, 20th Edition (2001), W.B. Saunders Company, Philadelphia
2. Demir A., Yarali N., Fisgin T., et al. Most reliable indices in differentiation between thalassemia trait and iron deficiency anemia. Pediatr Int 44 (2002) 612-616
3. van Zeben D., Bieger R., van Wermeskerken R.K., et al. Evaluation of microcytosis using serum ferritin and red blood cell distribution width. Eur J Haematol 44 (1990) 106-109
4. Aslan D., Gumruk F., Gurgey A., et al. Importance of RDW value in differential diagnosis of hypochrome anemias. Am J Hematol 69 (2002) 31-33
5. Akarsu S., Taskin E., Yilmaz E., et al. Treatment of iron deficiency anemia with intravenous iron preparations. Acta Haematol 116 (2006) 51-57
6. Go A.S., Yang J., Ackerson L.M., et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 113 (2006) 2713-2723
7. Muzzarelli S., and Pfisterer M. Anemia as independent predictor of major events in elderly patients with chronic angina. Am Heart J 152 (2006) 991-996
8. Sabatine M.S., Morrow D.A., Giugliano R.P., et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
9. Felker G.M., Allen L.A., Pocock S.J., et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50 (2007) 40-47
10. Tonelli M., Sacks F., Arnold M., et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117 (2008) 163-168
11. Ani C., and Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci 277 (2009) 103-108
12. Cavusoglu E., Chopra V., Gupta A., et al. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol (2009)
13. Felker G.M., Adams Jr. K.F., Gattis W.A., et al. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 (2004) 959-966
14. Das Gupta A., Hegde C., and Mistri R. Red cell distribution width as a measure of severity of iron deficiency in iron deficiency anaemia. Indian J Med Res 100 (1994) 177-183
15. Das Gupta A., and Abbi A. High serum transferrin receptor level in anemia of chronic disorders indicates coexistent iron deficiency. Am J Hematol 72 (2003) 158-161
16. Maury C.P., Andersson L.C., Teppo A.M., et al. Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann Rheum Dis 47 (1988) 972-978
17. Papadaki H.A., Kritikos H.D., Valatas V., et al. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 100 (2002) 474-482
18. Vreugdenhil G., Lowenberg B., Van Eijk H.G., et al. Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur J Clin Invest 22 (1992) 488-493
19. Gabrilove J.L. Introduction and overview of hematopoietic growth factors. Semin Hematol 26 2 Suppl 2 (1989) 1-4
20. Jelkmann W.E., Fandrey J., Frede S., et al. Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states. Ann N Y Acad Sci 718 (1994) 300-309 [discussion 309-11]
21. Lacombe C., and Mayeux P. The molecular biology of erythropoietin. Nephrol Dial Transplant 14 Suppl 2 (1999) 22-28
22. Macdougall I.C., and Cooper A. The inflammatory response and epoetin sensitivity. Nephrol Dial Transplant 17 Suppl 1 (2002) 48-52
23. Levine B., Kalman J., Mayer L., et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
24. Munger M.A., Johnson B., Amber I.J., et al. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77 (1996) 723-727
25. Deswal A., Petersen N.J., Feldman A.M., et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103 (2001) 2055-2059
26. Chiari M.M., Bagnoli R., De Luca P.D., et al. Influence of acute inflammation on iron and nutritional status indexes in older inpatients. J Am Geriatr Soc 43 (1995) 767-771
27. Pierce C.N., and Larson D.F. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20 (2005) 83-90
28. Horwich T.B., Hamilton M.A., Maclellan W.R., et al. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 8 (2002) 216-224
29. Kalantar-Zadeh K., Anker S.D., Horwich T.B., et al. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol 101 (2008) 89E-103E